This is a group of inherited conditions where the body doesn't make proteins correctly. Proteins are important building blocks in your body. When they aren't made right, it can cause various health problems, often affecting the heart, brain, and muscles.
Every report comes from a Lived member, sent anonymously.
Have you tried Mannose for Congenital Disorders of Glycosylation?
Congenital disorders of glycosylation (CDG) are a group of inherited conditions in which the body cannot properly build or attach sugar chains to proteins and fats. This process, called glycosylation, helps thousands of proteins fold, travel to the right place and do their jobs. When it goes wrong, many organs can be affected at once, which is why CDG often involves the brain, muscles, liver, gut, hormones and blood clotting together. CDG is an umbrella term rather than a single disease. More than 130 types are known, each named after the gene involved, such as PMM2-CDG, the most common type (once called CDG type Ia). Most types become apparent in infancy, often as weak muscle tone, slow growth, feeding problems or delayed development. Severity varies enormously: some babies are seriously ill from birth, while some people have mild symptoms found only in adulthood. Even relatives with the same type can be affected differently.
CDG is caused by a change in one of the many genes that control glycosylation. Nothing a parent did during pregnancy causes it, and there are no known environmental causes. Most types are inherited in an autosomal recessive pattern. Each parent carries one altered copy of the gene, usually without symptoms, and a child is affected only when they inherit an altered copy from both. When both parents are carriers, each pregnancy has a 25 percent chance of an affected child. A few types follow other patterns, including ones caused by a new genetic change that neither parent carries, so the chance of it happening again differs. Genetic counseling helps a family understand which pattern applies to them.
CDG is often suspected when a child has problems in several body systems that have no clear explanation, especially weak muscle tone and developmental delay together with liver, clotting or growth problems. Because the signs overlap with many other genetic and metabolic conditions, testing is needed to confirm it. A common first test looks at transferrin, a protein in the blood that normally carries a specific pattern of sugar chains. An abnormal pattern points to many of the most common types, though some types leave transferrin normal, so a normal result does not rule CDG out. Genetic testing, often sequencing of many genes or of all genes at once, identifies the specific type. Knowing the exact type matters because it shapes what to watch for and whether a type-specific treatment exists.
There is no approved treatment that corrects the underlying cause of any type of CDG, and for most types care focuses on managing symptoms and preventing complications. That care is usually coordinated by a team that may include a metabolic or genetics specialist, neurologist, gastroenterologist, cardiologist, eye doctor and therapists. Nutrition is often central in infancy. Some children need high-calorie feeds, help with reflux, or a feeding tube through the nose or directly into the stomach to grow well. Physical, occupational and speech therapy support movement, daily skills and communication. Other problems are treated in the usual ways, such as seizure medicines for seizures or thyroid hormone for an underactive thyroid. A few types have more targeted options. MPI-CDG, which affects the gut, liver and clotting and can cause low blood sugar but does not affect development, is treated with oral mannose, a simple sugar that bypasses the faulty step; it can greatly improve gut and clotting problems, though liver disease may not respond and the large daily amounts can cause diarrhea. Mannose does not help PMM2-CDG. Galactose, another sugar, has reduced bleeding and improved blood test results in some people with PGM1-CDG in small studies. For PMM2-CDG, acetazolamide (an older medicine used for glaucoma and some seizures) has improved coordination in a small trial, and other approaches are being studied, but none is yet standard care.
The outlook depends heavily on the type and on how severely a person is affected. In PMM2-CDG, about one in five affected babies does not survive the first year because several organs fail. Children who get through infancy usually become more stable, though many live with moderate intellectual disability, balance and coordination problems, and some do not walk independently. In adolescence and adulthood, nerve damage in the legs, curvature of the spine, vision loss from retinal changes and missing or incomplete puberty in girls can appear. Other types follow different courses, and for many very rare types little long-term information exists. Daily life often involves regular appointments with several specialists, therapy sessions, and periodic blood tests and eye, heart and development checks. Clotting abnormalities rarely cause trouble in ordinary daily life, but they need careful planning before any surgery or other procedure, so every new care team should know about the diagnosis. Families often find connection with other CDG families and patient organizations helpful, given how rare each type is.
Ask for an evaluation if a baby or child has weak muscle tone, poor growth or feeding, or developmental delay together with other unexplained problems such as abnormal liver tests, unusual fat distribution or crossed eyes. Adults with a diagnosis and families planning a pregnancy can ask for genetic counseling at any time. For someone with CDG, contact the care team promptly about a fever or infection, feeding that stops or vomiting that will not settle, unusual bruising or bleeding, or a bump to the head, since in PMM2-CDG infections and head injuries can trigger stroke-like episodes, sudden stroke-like symptoms described below. Sudden weakness on one side of the body or new confusion or unusual drowsiness needs emergency evaluation, as does a first seizure, a seizure that is longer or different from usual, or a seizure followed by weakness or confusion that does not clear. These can be a stroke-like episode, which usually improves over days to months, but they cannot be told apart from a true stroke, bleeding or brain infection without urgent tests.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Congenital Disorders of Glycosylation is like, what's helped you, or ask the community a question.